BridgeMD
Tests treatment safety and results for Stone, Kidney
Official title Effectiveness of Self-posturotherapy on the Elimination of Residual Fragments After Treatment of Lower Calyx Urinary Stones by Extracorporeal Lithotripsy or Retrograde Flexible Ureteroscopy.
ClinicalTrials.gov ID: NCT06793540
What this study is testing
- What it's testing
- The main objective of this study is to evaluate the effectiveness of an auto posturotherapy technique on the RFS at three months of patients treated for lower calyceal urinary stones by extracorporeal lithotripsy (ECL) or retrograde flexible ureteroscopy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Patient having read and signed the consent form for participation in the study Patient candidate for an intervention on a lower calyx stone \<15mm by...
- Patient treated by LEC, or patient treated by URSS and for whom the presence of lower calyceal fragments has been observed by endoscopy
- Absence of JJ stent (patients for whom a JJ stent was implanted after URSS or before LEC may be included as soon as it is removed)
You likely can't join if
- Patients presenting one of the following criteria will not be included in the study:
- Renal or ureteral malformation: ureteral stenosis, pyelo-ureteral junction syndrome, horseshoe kidney, para calyceal diverticulum, pelvic kidney.
- LEC session interrupted due to treatment intolerance
- Physical disability making posturotherapy impossible (particularly spinal, etc.), morbid obesity, major gastroesophageal reflux, heart or respiratory...
- Balance disorder which would not allow self-posturotherapy to be carried out alone.
- Patient under legal protection, under guardianship or under curatorship
See the full eligibility criteria
- Patient having read and signed the consent form for participation in the study Patient candidate for an intervention on a lower calyx stone \<15mm by LEC or URSS Patients meeting all of the following criteria may be...
- Patient treated by LEC, or patient treated by URSS and for whom the presence of lower calyceal fragments has been observed by endoscopy
- Absence of JJ stent (patients for whom a JJ stent was implanted after URSS or before LEC may be included as soon as it is removed)
- Patients presenting one of the following criteria will not be included in the study:
- Renal or ureteral malformation: ureteral stenosis, pyelo-ureteral junction syndrome, horseshoe kidney, para calyceal diverticulum, pelvic kidney.
- LEC session interrupted due to treatment intolerance
- Physical disability making posturotherapy impossible (particularly spinal, etc.), morbid obesity, major gastroesophageal reflux, heart or respiratory failure.
- Balance disorder which would not allow self-posturotherapy to be carried out alone.
- Patient under legal protection, under guardianship or under curatorship
- Posturotherapy carried out while wearing a JJ probe
- Posturotherapy carried out by a third party (physiotherapist or other)
- Pregnant or breastfeeding patient
- Patient not affiliated to the French social security system
- Impossibility of providing the subject with informed information and/or giving written informed consent: dementia, psychosis, disorders of consciousness, non-French speaking patient
- Treatment that may modify the clearance of fragments (beta blocker, diuretic, etc.)
- Patient included in another therapeutic study protocol
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, France
- Quint-Fonsegrives, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, France; Quint-Fonsegrives, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.